Heidi Forster Gertner

"Misleading" To Suggest A Biosimilar Is Inferior, FDA Draft Guidance Warns

2019 OPDP Enforcement Letters Target How Drug Risk Information Is Conveyed In Promotional Materials

FDA Doubles Down On MUsT Studies For Sunscreens And Issues Final Guidance On Absorption Studies That Will Likely Be Needed For Continued Marketing

Influencer Promo Guide: Best Practices For Drug And Device Firms

With The Statutory Deadline Approaching, FDA Issues A Proposed Sunscreens Rule